After the discovery of echinoderm microtubule associated protein like 4 (EML4)-ALK rearrangement in NSCLC, ALK-positive NSCLC patients obtained remarkably improved progression-free survival (PFS) and overall survival (OS) with ALK-TKIs treatment [1, 2]. The gene discussed is EML4; the disease is non-small cell lung carcinoma.